[HTML][HTML] Risk factors for the comorbidity of hypertension and renal cell carcinoma in the cardio-oncologic era and treatment for tumor-induced hypertension
Z Ba, Y Xiao, M He, D Liu, H Wang, H Liang… - Frontiers in …, 2022 - frontiersin.org
Advances in tumor diagnosis and treatment, especially the use of targeted therapies, have
remarkably improved the survival rate of patients with renal cell carcinoma (RCC) …
remarkably improved the survival rate of patients with renal cell carcinoma (RCC) …
Advances in tumor diagnosis and treatment, especially the use of targeted therapies, have remarkably improved the survival rate of patients with renal cell carcinoma …
K Ding, A Jain, J Yuan - Cardio-Oncology: Mechanisms and …, 2023 - books.google.com
The prevalence of hypertension (HTN) and renal cell carcinoma (RCC) keeps increasing. In
2019, one-third of people between 30 and 70 years old were estimated to have HTN …
2019, one-third of people between 30 and 70 years old were estimated to have HTN …
[HTML][HTML] Fat-containing renal cell carcinoma mimicking angiomyolipoma: a radiological and histopathological diagnostic challenge
A well-marginated fat-containing renal lesion gives strong suspicion of renal
angiomyolipoma (RAML) that usually requires no surgical intervention. Radiologically, renal …
angiomyolipoma (RAML) that usually requires no surgical intervention. Radiologically, renal …